Annual Current Liabilities:
$179.67M+$77.00M(+74.99%)Summary
- As of today, CYTK annual current liabilities is $179.67 million, with the most recent change of +$77.00 million (+74.99%) on December 31, 2024.
- During the last 3 years, CYTK annual current liabilities has risen by +$107.81 million (+150.03%).
- CYTK annual current liabilities is now at all-time high.
Performance
CYTK Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Liabilities:
$142.14M+$11.08M(+8.45%)Summary
- As of today, CYTK quarterly current liabilities is $142.14 million, with the most recent change of +$11.08 million (+8.45%) on September 30, 2025.
- Over the past year, CYTK quarterly current liabilities has increased by +$32.33 million (+29.44%).
- CYTK quarterly current liabilities is now -20.89% below its all-time high of $179.67 million, reached on December 31, 2024.
Performance
CYTK Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CYTK Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +75.0% | +29.4% |
| 3Y3 Years | +150.0% | +85.8% |
| 5Y5 Years | +590.4% | +415.5% |
CYTK Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +150.0% | -20.9% | +116.6% |
| 5Y | 5-Year | at high | +590.4% | -20.9% | +415.5% |
| All-Time | All-Time | at high | +3812.8% | -20.9% | +3463.4% |
CYTK Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $142.14M(+8.5%) |
| Jun 2025 | - | $131.06M(-17.9%) |
| Mar 2025 | - | $159.73M(-11.1%) |
| Dec 2024 | $179.67M(+75.0%) | $179.67M(+63.6%) |
| Sep 2024 | - | $109.81M(+6.8%) |
| Jun 2024 | - | $102.78M(+15.7%) |
| Mar 2024 | - | $88.86M(-13.5%) |
| Dec 2023 | $102.68M(+21.3%) | $102.68M(+32.1%) |
| Sep 2023 | - | $77.72M(+18.4%) |
| Jun 2023 | - | $65.62M(-12.8%) |
| Mar 2023 | - | $75.22M(-11.1%) |
| Dec 2022 | $84.62M(+17.8%) | $84.62M(+10.6%) |
| Sep 2022 | - | $76.50M(+14.4%) |
| Jun 2022 | - | $66.84M(-0.0%) |
| Mar 2022 | - | $66.85M(-7.0%) |
| Dec 2021 | $71.86M(+130.3%) | $71.86M(-11.1%) |
| Sep 2021 | - | $80.87M(+30.9%) |
| Jun 2021 | - | $61.77M(+71.9%) |
| Mar 2021 | - | $35.93M(+15.2%) |
| Dec 2020 | $31.20M(+19.9%) | $31.20M(+13.2%) |
| Sep 2020 | - | $27.57M(+21.5%) |
| Jun 2020 | - | $22.70M(+9.4%) |
| Mar 2020 | - | $20.74M(-20.3%) |
| Dec 2019 | $26.02M(+17.3%) | $26.02M(+20.9%) |
| Sep 2019 | - | $21.52M(-2.0%) |
| Jun 2019 | - | $21.96M(-16.4%) |
| Mar 2019 | - | $26.28M(+18.4%) |
| Dec 2018 | $22.19M(-31.6%) | $22.19M(+3.3%) |
| Sep 2018 | - | $21.49M(-21.2%) |
| Jun 2018 | - | $27.29M(-29.2%) |
| Mar 2018 | - | $38.55M(+18.8%) |
| Dec 2017 | $32.44M(-2.4%) | $32.44M(-23.4%) |
| Sep 2017 | - | $42.36M(+36.4%) |
| Jun 2017 | - | $31.06M(-15.6%) |
| Mar 2017 | - | $36.80M(+10.6%) |
| Dec 2016 | $33.26M(+5.1%) | $33.26M(+19.4%) |
| Sep 2016 | - | $27.86M(+6.0%) |
| Jun 2016 | - | $26.27M(+6.4%) |
| Mar 2016 | - | $24.68M(-22.0%) |
| Dec 2015 | $31.65M(+32.7%) | $31.65M(+5.0%) |
| Sep 2015 | - | $30.14M(+3.5%) |
| Jun 2015 | - | $29.11M(+14.7%) |
| Mar 2015 | - | $25.39M(+6.4%) |
| Dec 2014 | $23.86M | $23.86M(+83.7%) |
| Sep 2014 | - | $12.99M(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $16.92M(-14.5%) |
| Mar 2014 | - | $19.79M(-25.9%) |
| Dec 2013 | $26.70M(+275.8%) | $26.70M(-40.7%) |
| Sep 2013 | - | $45.01M(+32.2%) |
| Jun 2013 | - | $34.05M(+485.1%) |
| Mar 2013 | - | $5.82M(-18.1%) |
| Dec 2012 | $7.11M(+54.7%) | $7.11M(+54.8%) |
| Sep 2012 | - | $4.59M(+15.0%) |
| Jun 2012 | - | $3.99M(-10.7%) |
| Mar 2012 | - | $4.47M(-2.7%) |
| Dec 2011 | $4.59M(-37.3%) | $4.59M(-8.8%) |
| Sep 2011 | - | $5.03M(-8.6%) |
| Jun 2011 | - | $5.50M(-8.9%) |
| Mar 2011 | - | $6.04M(-17.5%) |
| Dec 2010 | $7.32M(-63.7%) | $7.32M(+12.9%) |
| Sep 2010 | - | $6.49M(-5.6%) |
| Jun 2010 | - | $6.88M(-60.8%) |
| Mar 2010 | - | $17.53M(-13.1%) |
| Dec 2009 | $20.19M(-11.8%) | $20.19M(-1.4%) |
| Sep 2009 | - | $20.47M(-12.0%) |
| Jun 2009 | - | $23.25M(+5.4%) |
| Mar 2009 | - | $22.06M(-3.6%) |
| Dec 2008 | $22.88M(-13.5%) | $22.88M(-6.5%) |
| Sep 2008 | - | $24.47M(-1.9%) |
| Jun 2008 | - | $24.95M(-5.1%) |
| Mar 2008 | - | $26.29M(-0.6%) |
| Dec 2007 | $26.45M(+0.2%) | $26.45M(+0.8%) |
| Sep 2007 | - | $26.24M(+7.6%) |
| Jun 2007 | - | $24.39M(+2.3%) |
| Mar 2007 | - | $23.85M(-9.6%) |
| Dec 2006 | $26.39M(+134.3%) | $26.39M(+112.8%) |
| Sep 2006 | - | $12.40M(+16.5%) |
| Jun 2006 | - | $10.65M(+10.0%) |
| Mar 2006 | - | $9.69M(-14.0%) |
| Dec 2005 | $11.26M(+2.0%) | $11.26M(+4.6%) |
| Sep 2005 | - | $10.76M(+2.7%) |
| Jun 2005 | - | $10.48M(-13.4%) |
| Mar 2005 | - | $12.10M(+9.6%) |
| Dec 2004 | $11.04M(+48.2%) | $11.04M(+2.3%) |
| Sep 2004 | - | $10.79M(+3.1%) |
| Jun 2004 | - | $10.47M(+13.4%) |
| Mar 2004 | - | $9.23M(-2.4%) |
| Dec 2003 | $7.45M(-20.5%) | $9.46M |
| Dec 2002 | $9.38M(-3.8%) | - |
| Dec 2001 | $9.74M | - |
FAQ
- What is Cytokinetics, Incorporated annual current liabilities?
- What is the all-time high annual current liabilities for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual current liabilities year-on-year change?
- What is Cytokinetics, Incorporated quarterly current liabilities?
- What is the all-time high quarterly current liabilities for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly current liabilities year-on-year change?
What is Cytokinetics, Incorporated annual current liabilities?
The current annual current liabilities of CYTK is $179.67M
What is the all-time high annual current liabilities for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual current liabilities is $179.67M
What is Cytokinetics, Incorporated annual current liabilities year-on-year change?
Over the past year, CYTK annual current liabilities has changed by +$77.00M (+74.99%)
What is Cytokinetics, Incorporated quarterly current liabilities?
The current quarterly current liabilities of CYTK is $142.14M
What is the all-time high quarterly current liabilities for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly current liabilities is $179.67M
What is Cytokinetics, Incorporated quarterly current liabilities year-on-year change?
Over the past year, CYTK quarterly current liabilities has changed by +$32.33M (+29.44%)